GlassScriptPhysician profile
Kevin K Seeras
NPI 1992199236
$44,034.80
in general payments reported to CMS, 2019-2025
18 companies · $24K in 2025
The $24K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $95.33 · 2021: $554 · 2022: $6,848 · 2023: $178 · 2024: $12K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $28K · Consulting Fee: $6,000 · Food and Beverage: $2,588 · Travel and Lodging: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $27,604.30 |
| Consulting Fee | $6,000.00 |
| Food and Beverage | $2,588.05 |
| Travel and Lodging | $119.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $35,826.36 | 2021-2025 | Da Vinci Surgical System |
| Distalmotion US | $6,100.00 | 2024 | Dexter L6 Robot |
| Endogastric Solutions, INC | $419.23 | 2024 | Esophyx |
| Novo Nordisk INC | $234.86 | 2022-2024 | Wegovy |
| Covidien LP | $225.78 | 2019 | |
| Tela Bio, INC. | $221.27 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $187.86 | 2021 | |
| Boston Scientific Corporation | $184.68 | 2021 | |
| Standard Bariatrics, INC. | $161.24 | 2021-2022 | |
| Davol INC. | $123.73 | 2024 | Phasix Mesh |
| Dilon Technologies, INC. | $123.64 | 2025 | Hemoblast Bellows |
| Medtronic Vascular, INC. | $95.33 | 2020 | |
| Innocoll Pharmaceuticals Limited | $34.26 | 2021 | |
| Conmed Corporation | $24.52 | 2025 | Airseal |
| Regeneron Healthcare Solutions, INC. | $23.10 | 2025 | Dupixent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.30 | 2025 | |
| Ethicon US, LLC | $14.23 | 2024 | Stratafix |
| Smith+Nephew, INC. | $13.41 | 2023 | Pico 14, Renasys Go V2 Home |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Seeras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.